Covaxin approval | WHO group likely to reconvene on Nov 3 for final risk-benefit assessmentsource https://www.indiatoday.in/coronavirus-outbreak/story/covaxin-approval-who-bharat-biotech-covid-1870237-2021-10-27?utm_source=rss
Wednesday, 27 October 2021
Covaxin approval | WHO group likely to reconvene on Nov 3 for final risk-benefit assessment
Covaxin approval | WHO group likely to reconvene on Nov 3 for final risk-benefit assessmentsource https://www.indiatoday.in/coronavirus-outbreak/story/covaxin-approval-who-bharat-biotech-covid-1870237-2021-10-27?utm_source=rss
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment